Market Segmentation:
- By Product Type
- Abdominal Aortic Aneurysm Stent Grafts
- Thoracic Aortic Aneurysm Stent Grafts
- Fenestrated Stent Grafts
- Branched Stent Grafts
- Others (Aorto-Uni-Iliac Stent Grafts, Aorto-Bi-Iliac Stent Grafts)
- By Aneurysm Type
- Abdominal Aortic Aneurysm
- Thoracic Aortic Aneurysm
- Others (Thoracoabdominal Aortic Aneurysm, Aortic Arch Aneurysm)
- By End-User
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Others (Catheterization Laboratories, Research Institutes)
- By Anatomy
- Infrarenal Aneurysms
- Pararenal Aneurysms
- Suprarenal Aneurysms
- Others (Thoracoabdominal Aneurysms, Aortic Arch Aneurysms)
- By Material
- Polyester
- Polytetrafluoroethylene (PTFE)
- Nitinol
- Others (Dacron, ePTFE)
- By Delivery System
- Bifurcated Delivery Systems
- Aorto-Uni-Iliac Delivery Systems
- Aorto-Bi-Iliac Delivery Systems
- Others (Fenestrated Delivery Systems, Branched Delivery Systems)
- By Regions
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Frequently Asked Questions
The current market size of the Aortic Aneurysm Stent Grafts industry is US$ 2.1 billion.
Increasing prevalence of aortic aneurysms, aging population, technological advancements in stent graft design, preference for minimally invasive procedures, rising healthcare expenditure, and improving access to healthcare in emerging markets.
High cost of stent graft procedures, risks associated with endovascular repairs, stringent regulatory approval process, lack of skilled healthcare professionals, and reimbursement challenges in certain regions.
The leading component segment in the Aortic Aneurysm Stent Grafts Market is the abdominal aortic aneurysm stent grafts segment, used for treating abdominal aortic aneurysms.
Medtronic, Endologix, W. L. Gore & Associates, Cook Medical, Terumo Corporation, Cardinal Health, MicroPort Scientific Corporation, Lombard Medical, Jotec GmbH, and TriVascular Technologies, Inc.
The Global Aortic Aneurysm Stent Grafts Market is expected to reach US$ 3.8 Bn in 2031 with a growth rate of 7.8% during the forecast period of 2024-2031.
Increasing prevalence of aortic aneurysms, aging population, technological advancements, preference for minimally invasive procedures, rising healthcare expenditure, improving access to healthcare in emerging markets, and favorable reimbursement policies.